How AI is Compressing Drug Development and Manufacturing Timelines

Pharmaceutical formulation and manufacturing have long been defined by slow, costly, iterative experimentation, with years of trial and error required before a viable product emerges.

This panel explores how AI is rewriting that process from the ground up. On the formulation side, machine learning models trained on real experimental data, combined with high throughput automation, are replacing blind screening with closed loop, predictive intelligence that identifies optimal compositions for solubility, stability, bioavailability, and release kinetics across injectable, oral, and RTU dosage forms. That same predictive philosophy is now extending downstream into manufacturing, where open, interoperable process ecosystems paired with AI driven optimization tools are helping plants improve performance, reduce downtime, and de-risk scale-up.

The discussion will examine how this shift is compressing development timelines, cutting material waste, and turning formulation and manufacturing from reactive art into predictive, data driven science, and what it will take for the industry to trust and adopt these tools at scale.